{"id":"https://openalex.org/W2005754580","doi":"https://doi.org/10.1177/00912700122012607","title":"A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects","display_name":"A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W2005754580","doi":"https://doi.org/10.1177/00912700122012607","mag":"2005754580","pmid":"https://pubmed.ncbi.nlm.nih.gov/11583480"},"language":"en","primary_location":{"id":"doi:10.1177/00912700122012607","doi":"https://doi.org/10.1177/00912700122012607","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912700122012607","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111625849","display_name":"Aziz Karim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aziz Karim","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois 60077, USA","Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois 60077, USA","institution_ids":[]},{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111754025","display_name":"Aziz L. Laurent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aziz Laurent","raw_affiliation_strings":["PPD Development, Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Development, Austin, Texas","institution_ids":["https://openalex.org/I1296342797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019287037","display_name":"Margaret Slater","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret E. Slater","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045035998","display_name":"Michael E. Kuss","orcid":"https://orcid.org/0000-0001-9668-9532","observed_orcids":["https://orcid.org/0000-0001-9668-9532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael E. Kuss","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100610506","display_name":"Jiang X. Qian","orcid":"https://orcid.org/0000-0002-0476-3596","observed_orcids":["https://orcid.org/0000-0002-0476-3596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiang Qian","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090370925","display_name":"Sharon L. Crosby\u2010Sessoms","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon L. Crosby\u2010Sessoms","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036550158","display_name":"Richard C. Hubbard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard C. Hubbard","raw_affiliation_strings":["Pharmacia Research and Development, Skokie, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia Research and Development, Skokie, Illinois","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":4.6354,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.94765175,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"41","issue":"10","first_page":"1111","last_page":"1119"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0640999972820282,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10189","display_name":"Anesthesia and Pain Management","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parecoxib-sodium","display_name":"parecoxib sodium","score":0.9390000104904175},{"id":"https://openalex.org/keywords/valdecoxib","display_name":"valdecoxib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7329999804496765},{"id":"https://openalex.org/keywords/intramuscular-administration","display_name":"intramuscular administration","score":0.9679999947547913},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cox-2-selective-inhibitors","display_name":"COX-2 selective inhibitors","score":0.8740000128746033},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.9660000205039978},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7559999823570251},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2779528491","wikidata":"https://www.wikidata.org/wiki/Q347613","display_name":"Valdecoxib","level":5,"score":0.979707658290863},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8181776404380798},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7761348485946655},{"id":"https://openalex.org/C2779262571","wikidata":"https://www.wikidata.org/wiki/Q347941","display_name":"Parecoxib","level":3,"score":0.7704660892486572},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6619576215744019},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.6404823660850525},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5745059847831726},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5439221858978271},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.50614994764328},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.45868778228759766},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.45569437742233276},{"id":"https://openalex.org/C2776291583","wikidata":"https://www.wikidata.org/wiki/Q432083","display_name":"Intramuscular injection","level":2,"score":0.43141716718673706},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.4049256145954132},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2780637741088867},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.25283724069595337},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.1734330952167511},{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/00912700122012607","doi":"https://doi.org/10.1177/00912700122012607","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912700122012607","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:11583480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11583480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W161486224","https://openalex.org/W1972733540","https://openalex.org/W1973788284","https://openalex.org/W1976654542","https://openalex.org/W1985813197","https://openalex.org/W1997364548","https://openalex.org/W2008574207","https://openalex.org/W2034323095","https://openalex.org/W2039358393","https://openalex.org/W2078736915","https://openalex.org/W2092193486","https://openalex.org/W2149233326","https://openalex.org/W2398006323","https://openalex.org/W4234468755","https://openalex.org/W4292059951"],"related_works":["https://openalex.org/W2033872615","https://openalex.org/W2607825471","https://openalex.org/W7098940630","https://openalex.org/W2021455694","https://openalex.org/W2355160397","https://openalex.org/W2000699817","https://openalex.org/W4256258724","https://openalex.org/W2015825523","https://openalex.org/W2103685579","https://openalex.org/W2402374869"],"abstract_inverted_index":{"A":[0],"single-center,":[1],"double-blind,":[2],"placebo-controlled,":[3],"randomized":[4],"study":[5],"was":[6,158,187],"conducted":[7],"to":[8,48,55,110,126,130,135,160,181,216,226,240],"determine":[9],"the":[10,22,33,161,188,196,211,227],"pharmacokinetics,":[11],"safety,":[12],"and":[13,21,97,112,133,152,199],"tolerability":[14],"of":[15,27,32,53,91,94,145,169,185,201,213,219,229,232,238],"single,":[16],"rising":[17],"intramuscular":[18],"(i.m.)":[19],"doses":[20,224],"single":[23,222],"maximum":[24,228],"tolerated":[25],"dose":[26,60,111,206],"parecoxib":[28,65,146,203],"sodium,":[29],"a":[30],"prodrug":[31,157],"novel":[34],"COX-2":[35],"selective":[36],"anti-inflammatory":[37],"analgesic":[38],"drug":[39,122],"valdecoxib,":[40,96,170,202],"in":[41,58,166,210],"56":[42],"healthy":[43],"male":[44],"volunteers,":[45],"ages":[46],"18":[47],"45":[49],"years":[50],"inclusive.":[51],"Cohorts":[52],"up":[54,225,239],"6":[56],"subjects":[57],"each":[59],"schedule":[61],"were":[62,101,119,147,243],"administered":[63,209],"either":[64],"sodium":[66,204],"(1":[67],"mg,":[68,70,72,74,76],"2":[69],"5":[71],"10":[73],"20":[75,241],"or":[77,80],"40":[78,217,230],"mg)":[79],"matching":[81],"placebo.":[82],"Following":[83],"i.m.":[84,140,223],"administration,":[85,141],"serial":[86],"blood":[87],"samples":[88],"for":[89,121],"measurement":[90],"plasma":[92,143,167],"concentrations":[93,144,168,237],"parecoxib,":[95,233],"valdecoxib":[98],"metabolite":[99,191],"(M1)":[100],"collected":[102],"at":[103],"predetermined":[104],"intervals":[105],"(from":[106,124],"15":[107,150],"minutes":[108,151],"prior":[109],"through":[113],"96":[114],"hours":[115,137],"postdose).":[116,138],"Urine":[117],"collections":[118],"obtained":[120],"assay":[123],"-12":[125],"0":[127,129],"hours,":[128,132],"12":[131,134],"24":[136],"After":[139],"peak":[142],"reached":[148],"within":[149],"then":[153],"declined":[154,172],"rapidly":[155],"as":[156,234,236],"converted":[159],"active":[162,190],"moiety,":[163],"valdecoxib.":[164],"Change":[165],"which":[171,186],"more":[173],"slowly":[174],"(t(1/2)":[175],"=":[176],"5.4-9.9":[177],"hours),":[178],"reflected":[179],"transformation":[180],"several":[182],"metabolites,":[183],"one":[184],"minor":[189],"M1.":[192],"As":[193],"measured":[194],"by":[195],"AUC(0-infinity),":[197],"Cmax,":[198],"XU(0-24)":[200],"demonstrated":[205],"proportionality":[207],"when":[208],"range":[212],"1":[214],"mg":[215,218,231],"parecoxib.":[220],"All":[221],"well":[235,244],"mg/ml,":[242],"tolerated.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}